Data as of Dec 26
| +3.02 / +2.48%|
The 19 analysts offering 12-month price forecasts for Pharmacyclics Inc have a median target of 160.00, with a high estimate of 225.00 and a low estimate of 111.00. The median estimate represents a +28.14% increase from the last price of 124.86.
The current consensus among 21 polled investment analysts is to Buy stock in Pharmacyclics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.